Advanced search
Start date
Betweenand

Identification of virological, genetic and immunological factors associated with the phenotype of HIV disease non-progression: a study of HIV virulence markers, CCR5 co-receptor genotyping and expression of broad panel of cytokines (cDNA microarrays) in peripheral blood samples of patients with HIV progressors and non-progressors followed up at Casa da AIDS [SIDA Healthcare Services]

Grant number: 01/00729-3
Support type:Regular Research Grants
Duration: August 01, 2001 - October 31, 2005
Field of knowledge:Biological Sciences - Immunology
Principal Investigator:Edecio Cunha Neto
Grantee:Edecio Cunha Neto
Home Institution: Instituto do Coração Professor Euryclides de Jesus Zerbini (INCOR). Hospital das Clínicas da Faculdade de Medicina da USP (HCFMUSP). Secretaria da Saúde (São Paulo - Estado). São Paulo , SP, Brazil

Abstract

Experimental HIV-1vaccines which underwent clinical assessment in humans so far had limited or no success, and progress in epitope constitution may help improve vaccine efficacy. To identify immunodominant and potentially protective human CD4+ T cell epitopes in HIV-1, we used the TEPITOPE algorithm to screen the most conserved regions of the whole genome of HIV-1 subtype B consensus sequence, that would most likely bind multiple HLA-DR molecules and tested their recognition by T cells from sensitized individuals. The eighteen most promiscuous peptides were selected and the actual promiscuity of HLA binding was assessed by direct assays to 9 prevalent HLA-DR molecules. Synthetic peptides were tested with IFN-y ELISPOT assays on peripheral blood mononuclear cells (PBMC) from chronically HIV-1 infected patients (8 long-term nonprogressors (LTNP) and 24 under antiretroviral treatment) and 8 uninfected controls. PBMC from 29 out of the 32 HIV-1+ patients (91%) recognized at least one of the promiscuous peptides, while none of the healthy controls recognized peptides. All 18 peptides were recognized, and each peptide was recognized by at least 7 patients; 44% of the patients recognized 5 or more peptides, and 19% of patients recognized 10 or more peptides. A combination of the three most frequently recognized peptides elicited responses in 75% of patients. Similar responses were obtained in CD8+ T cell-depleted PBMC, and apparently this response was not associated to particular HLA-DR alleles. In silico prediction of promiscuous epitopes led to the identification of naturally immunodominant CD4+ T cell epitopes recognized by PBMC from a significant proportion of a genetically heterogeneous patient population exposed to HIV-1. This combination of CD4+ T cell epitopes – 11 of them not described before – may have the potential for inclusion in a vaccine against HIV-1, allowing the immunization of genetically distinct populations. (AU)

Articles published in Agência FAPESP Newsletter about the research grant
Brazilian AIDS vaccine to be tested in monkeys 
Articles published in Pesquisa FAPESP Magazine about the research grant:
The third wave 

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
FONSECA‚ S.G.; COUTINHO-SILVA‚ A.; FONSECA‚ L.A.M.; SEGURADO‚ A.C.; MORAES‚ S.L.; RODRIGUES‚ H.; HAMMER‚ J.; KALLÁS‚ E.G.; SIDNEY‚ J.; SETTE‚ A.; OTHERS. Identification of novel consensus CD4 T-cell epitopes from clade B HIV-1 whole genome that are frequently recognized by HIV-1 infected patients. AIDS, v. 20, n. 18, p. 2263-2273, 2006.
P.C. TEIXEIRA; L.K. IWAI; A.C.K. KURAMOTO; R. HONORATO; A. FIORELLI; N. STOLF; J. KALIL; E. CUNHA-NETO. Proteomic inventory of myocardial proteins from patients with chronic Chagas' cardiomyopathy. Brazilian Journal of Medical and Biological Research, v. 39, n. 12, p. 1549-1562, Dez. 2006.

Please report errors in scientific publications list by writing to: cdi@fapesp.br.
Filed patent(s) as a result of this research project

EPITOPES, COMBINED EPITOPES, USE OF EPITOPES OR THEIR COMBINATION, COMPOSITION, USES OF THE COMPOSITION, ANTI- HIV-I PROPHYLACTIC VACCINES, THERAPEUTIC VACCINES, METHOD FOR THE IDENTIFICATION OF EPITOPES AND METHODS FOR TREATMENT AND PREVENTION EP20060775031 - Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) ; Fundação Zerbini ; Universidade de São Paulo (USP) . Edecio Cunha Neto; Jorge Elias Kalil Filho; Simone Gonçalves da Fonseca - April 2006, 09

EPITOPES, COMBINED EPITOPES, USE OF EPITOPES OR THEIR COMBINATION, COMPOSITION, USES OF THE COMPOSITION, ANTI- HIV-I PROPHYLACTIC VACCINES, THERAPEUTIC VACCINES, METHOD FOR THE IDENTIFICATION OF EPITOPES AND METHODS FOR TREATMENT AND PREVENTION PCT/BR2006/000175 - Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) ; Fundação Zerbini ; Universidade de São Paulo (USP) . Edecio Cunha Neto; Jorge Elias Kalil Filho; Simone Gonçalves da Fonseca - April 2006, 09

EPÍTOPOS, COMBINAÇÃO DE EPÍTOPOS, USOS DE EPÍTOPOS OU SUA COMBINAÇÃO, COMPOSIÇÃO, USOS DA COMPOSIÇÃO, VACINAS PROFILÁTICAS ANTI-HIV-1, VACINAS TERAPÊUTICAS, MÉTODO PARA A IDENTIFICAÇÃO DE EPÍTOPOS E MÉTODOS PARA O TRATAMENTO OU PREVENÇÃO PI0504117-1 - Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) ; Fundação Zerbini ; Universidade de São Paulo (USP) . Edecio Cunha Neto; Jorge Elias Kalil Filho; Simone Gonçalves da Fonseca - September 2005, 05

EPITOPES, COMBINED EPITOPES, USE OF EPITOPES OR THEIR COMBINATION, COMPOSITION, USES OF THE COMPOSITION, ANTI- HIV-I PROPHYLACTIC VACCINES, THERAPEUTIC VACCINES, METHOD FOR THE IDENTIFICATION OF EPITOPES AND METHODS FOR TREATMENT AND PREVENTION US12/073,401 - Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) ; Fundação Zerbini ; Universidade de São Paulo (USP) . Edecio Cunha Neto; Jorge Elias Kalil Filho; Simone Gonçalves da Fonseca - March 2008, 05